Clinical Trials for Immune-mediated Thrombotic Thrombocytopenic Purpura

Find clinical trials for immune-mediated thrombotic thrombocytopenic purpura. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

NCT ID: NCT06831058

This clinical trial is studying a medication called efgartigimod to see if it can help patients with a rare autoimmune disorder known as immune-mediated thrombotic thrombocytopenic purpura (iTTP). ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions